E-MIMR-102 - Transcription profiling of human lung adenocarcinoma A549 cells treated with vehicle (DMSO) or Etoposide (ETOP, 10 uM ), Benzo(a)pyrene Cryptolepineand 2-Amino-1-methyl-6-phenylimidazo [4,5-b]pyridine for 6 h, 16 h, 24 h, 48 h and 72 h
Released on 1 June 2006, last updated on 3 May 2014
Title: Prediction of cell cycle behaviour in response to DNA damage agents via transcriptomic approach
Description: Human lung adenocarcinoma A549 cells were treated with vehicle (DMSO) or Etoposide (ETOP, 10 µM ), Benzo(a)pyrene (BaP, 25 µM ), Cryptolepine ( CLP, 2.5 µM) and 2-Amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP, 50 µM) for 6 h, 16 h, 24 h, 48 h and 72 h.
transcription profiling by array, compound treatment , time series